Skip to content
★ Sign in to follow
CH

Cambridge Heart Inc Stock: price and insider trades · United States

No insider purchase over the last 90 days. The latest, by Martins Luis, was filed 22 Dec 2010.

Cambridge Heart Inc: what insiders have been doing

Cambridge Heart Inc is a listed company. Its insiders report their share dealings to SEC (Form 4). Nothing new has been filed by managers of Cambridge Heart Inc in twelve months, the latest record being from 23 November 2011.

The full history, which starts in 2006, counts 9 purchases against 20 sales.

Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Insider Decl.
50
Thresholds
n/a
Buy Volume
€2M
9 ops. · all time
Sell Volume
€2M
20 ops. · all time
Last declaration on 23 November 2011
Declarations50 total
  • ◆
    Chairman of the BoardExecutives
    25,000 USD0SEC
    170,068 shares@ US$0.147Common Stock, $.001 par valueSEC:0001455244-11-000032:0
  • ●
    10% OwnerExecutives
    35,000 USD0SEC
    238,095 shares@ US$0.147Common StockSEC:0001455244-11-000034:0
  • ◆
    Chairman of the BoardExecutives
    32,622 USD0SEC
    304,878 shares@ US$0.107Common Stock, $.001 par valueSEC:0001491877-10-000052:0
  • ▲
    10% OwnerExecutives
    200,000 USD0SEC
    1,000,000 shares@ US$0.20Common StockSEC:0001491877-10-000051:0
    Canonical exit: 20 Mar 2011 (T+90)
  • ◆
    10% OwnerExecutives
    205,518 USD0SEC
    1,920,732 shares@ US$0.107Common StockSEC:0001491877-10-000051:1
  • ◆
    10% OwnerExecutives
    163,646 USD0SEC
    1,152,439 shares@ US$0.142Common StockSEC:0001455244-10-000114:0
  • ◆
    10% OwnerExecutives
    155,854 USD0SEC
    1,097,561 shares@ US$0.142Common StockSEC:0001455244-10-000105:0
  • ◆
    Chairman of the BoardExecutives
    25,976 USD0SEC
    182,927 shares@ US$0.142Common Stock, $0.001 par valueSEC:0001435420-10-000003:0
  • ◆
    DirectorExecutives
    195,732 USD0SEC
    1,829,269 shares@ US$0.107Common Stock, $0.001 par valueSEC:0001455244-10-000103:0
  • ◆
    DirectorExecutives
    155,854 USD0SEC
    1,097,561 shares@ US$0.142Common Stock, $0.001 par valueSEC:0001455244-10-000103:1
  • ▲
    Interim President and CEOExecutives
    72,500 USD0SEC
    50,000 shares@ US$1.45Common StockSEC:0001373185-07-000033:0
    Canonical exit: 17 Feb 2008 (T+90)
  • ▼
    DirectorExecutives
    44,380 USD0SEC
    14,000 shares@ US$3.17Common StockSEC:0001373185-07-000032:0
  • ▼
    DirectorExecutives
    19,020 USD0SEC
    6,000 shares@ US$3.17Common StockSEC:0001373185-07-000032:1
  • ▲
    Int. President and CEOExecutives
    204,000 USD0SEC
    50,000 shares@ US$4.08Common StockSEC:0001396093-07-000013:0
    Canonical exit: 23 Aug 2007 (T+90)
  • ◆
    DirectorExecutives
    0SEC
    175,000 shares0Common StockSEC:0001396093-07-000003:0
  • ▲
    Int. President and CEOExecutives
    189,000 USD0SEC
    50,000 shares@ US$3.78Common StockSEC:0001396093-07-000002:0
    Canonical exit: 13 Aug 2007 (T+90)
  • ▼
    DirectorExecutives
    27,375 USD0SEC
    7,500 shares@ US$3.65Common StockSEC:0001396093-07-000001:0
  • ▼
    DirectorExecutives
    9,125 USD0SEC
    2,500 shares@ US$3.65Common StockSEC:0001396093-07-000001:1
  • ▼
    DirectorExecutives
    9,250 USD0SEC
    2,500 shares@ US$3.70Common StockSEC:0001396093-07-000001:2
  • ▼
    DirectorExecutives
    18,500 USD0SEC
    5,000 shares@ US$3.70Common StockSEC:0001396093-07-000001:3
  • ▼
    Vice PresidentExecutives
    105,000 USD0SEC
    35,000 shares@ US$3.00Common StockSEC:0001278819-06-000049:0
  • ▼
    Vice PresidentExecutives
    160,684 USD0SEC
    51,667 shares@ US$3.11Common StockSEC:0001278819-06-000049:1
  • ▼
    DirectorExecutives
    110,800 USD0SEC
    40,000 shares@ US$2.77Common StockSEC:0001278819-06-000048:0
  • ▼
    CFO and VP, Fin. and Admin.Executives
    279,066 USD0SEC
    93,333 shares@ US$2.99Common StockSEC:0001278819-06-000047:0
  • ▼
    CFO and VP, Fin. and Admin.Executives
    15,200 USD0SEC
    5,000 shares@ US$3.04Common StockSEC:0001278819-06-000047:1

25 of 50 declarations

About Cambridge Heart Inc

Cambridge Heart Inc is a company focused on developing medical technologies for the diagnosis and treatment of heart diseases. It is listed on NASDAQ under the symbol XNAS.